DekaBank Deutsche Girozentrale
RGLS

DekaBank Deutsche Girozentrale’s Regulus Therapeutics RGLS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-204
Closed -$160K – 1034
2016
Q1 		$160K Sell
204
-15
-7% -$11.9K ﹤0.01% 883
2015
Q4 		$242K Buy
219
+4
+2% +$4.01K ﹤0.01% 830
2015
Q3 		$169K Buy
215
+8
+4% +$8.21K ﹤0.01% 896
2015
Q2 		$272K Buy
207
+9
+5% +$14.5K ﹤0.01% 813
2015
Q1 		$401K Sell
198
-15
-7% -$32.6K 0.01% 773
2014
Q4 		$411K Hold
213
– – 0.01% 731
2014
Q3 		$174K Buy
213
+5
+2% +$4.23K ﹤0.01% 838
2014
Q2 		$201K Sell
208
-5
-2% -$4.29K ﹤0.01% 750
2014
Q1 		$230K Buy
+213
New +$236K ﹤0.01% 699

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return